56
Participants
Start Date
June 12, 2018
Primary Completion Date
December 30, 2022
Study Completion Date
April 21, 2023
AMXT1501
AMXT 1501 dicaprate is D-lys(palmitoyl)-spermine dicaprate salt in 40 mg or 200 mg (free base content) enterically-coated capsules
DFMO
DFMO is DL-2-(difluoromethyl) ornithine monohydrochloride monohydrate 250 mg in hard gelatin capsules
Virginia Cancer Center, Fairfax
MD Anderson Cancer Center, Houston
Next Oncology - San Antonio, San Antonio
Next Oncology - Austin Midtown, Austin
Lead Sponsor
Aminex Therapeutics, Inc.
INDUSTRY